- Home
- TARS vs LOB Comparison
TARS vs LOB Comparison
Compare TARS & LOB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TARS
- LOB
- Stock Information
- Founded
- TARS 2016
- LOB 2008
- Country
- TARS United States
- LOB United States
- Employees
- TARS N/A
- LOB N/A
- Industry
- TARS Medicinal Chemicals and Botanical Products
- LOB Major Banks
- Sector
- TARS Health Care
- LOB Finance
- Exchange
- TARS Nasdaq
- LOB Nasdaq
- Market Cap
- TARS 1.7B
- LOB 1.5B
- IPO Year
- TARS 2020
- LOB 2015
- Fundamental
- Price
- TARS $40.00
- LOB $32.17
- Analyst Decision
- TARS Strong Buy
- LOB Buy
- Analyst Count
- TARS 7
- LOB 3
- Target Price
- TARS $67.14
- LOB $42.33
- AVG Volume (30 Days)
- TARS 522.7K
- LOB 258.2K
- Earning Date
- TARS 08-11-2025
- LOB 07-23-2025
- Dividend Yield
- TARS N/A
- LOB 0.38%
- EPS Growth
- TARS N/A
- LOB N/A
- EPS
- TARS N/A
- LOB 1.21
- Revenue
- TARS $233,674,000.00
- LOB $406,003,000.00
- Revenue This Year
- TARS $122.94
- LOB $41.81
- Revenue Next Year
- TARS $44.14
- LOB $10.77
- P/E Ratio
- TARS N/A
- LOB $26.38
- Revenue Growth
- TARS 449.03
- LOB N/A
- 52 Week Low
- TARS $20.08
- LOB $22.68
- 52 Week High
- TARS $57.28
- LOB $50.57
- Technical
- Relative Strength Index (RSI)
- TARS 42.88
- LOB 54.16
- Support Level
- TARS $39.41
- LOB $31.97
- Resistance Level
- TARS $43.33
- LOB $34.42
- Average True Range (ATR)
- TARS 1.67
- LOB 1.09
- MACD
- TARS -0.06
- LOB -0.06
- Stochastic Oscillator
- TARS 13.97
- LOB 40.48
About TARS Tarsus Pharmaceuticals Inc.
Tarsus Pharmaceuticals Inc is a commercial-stage biopharmaceutical company focused on the development and commercialization of therapeutics, starting with eye care. The company is focused on the development and commercialization of first-in-class therapeutic candidates to provide treatment for ophthalmic conditions. The company's candidate XDEMVY is a novel investigational eye drop to treat blepharitis caused by the infestation of Demodex mites, referred to as Demodex blepharitis.
About LOB Live Oak Bancshares Inc.
Live Oak Bancshares Inc operates as the bank holding company for the Live Oak Banking Company. The company specializes in lending and deposit-related services to small businesses nationwide. The company identifies and extends lending to credit-worthy borrowers both within specific industries, also called verticals, through expertise within those industries, and more broadly to select borrowers outside of those industries. A portion of the loans originated by the Bank are partially guaranteed by the Small Business Administration under the 7(a) Loan Program and the U.S. Department of Agriculture Rural Energy for America Program, Water and Environmental Program, Business and Industry and Community Facilities loan programs.